Õ¬ÄÐÊÓƵ

Overview

The UCL Therapeutic Acceleration Support (TAS) Fund is supported by funding from the MRC Impact Acceleration Account (IAA) and the NIHR UCLH, GOSH and Moorfields Biomedical Research Centres (BRC) affiliated with UCL.

It aims to accelerate the transition from discovery science to the early stages of therapeutic, device and diagnostic development by providing responsive and flexible funding to support preliminary translational work to de-risk projects and prepare applications for further, larger translational funding schemes.

DeadlineÌý Ìý Ìý Ìý Ìý Ìý Ìý Ìý :ÌýWednesday 26^th April 2023 - 5pm
Funding available :Ìý£60 - 80k
DurationÌý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý:Ìý12 months
Research areaÌý Ìý Ìý Ìý:ÌýCell and gene therapies, regenerative medicine, medical devices, diagnostics, small molecules, biologics, repurposing and data/digital-based healthcare innovations

Remit of this Call

• All modalities of therapy and diagnostics including engineering/medical technology, bioinformatics approaches & psychological interventions can be submitted for consideration. Applications from across the breadth of diseases researched in UCL and its partner hospitals will be welcomed.
• Applications including an industry partner are encouraged
• Before applying please read the to ensure that your project is in remit.ÌýApplications that do not conform to the brief will not be considered for funding.

Further DetailsÌý & Application

The application form and applicant guidance are available from ÌýÌý

Application Deadline

Wednesday 26 April 17:00 GMTÌýÌý

Enquiries about the scheme should be addressed to Helen Cooksley (h.cooksley@ucl.ac.uk) in the Translational Research Office.

Interested to stay informed of upcoming news, events and funding calls?

• Subscribe to our newsletterÌýand you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations
• FollowÌýus on social media (,Ìý)Ìýand stay tuned to our news and updates.

Exclusive capabilities resource for you:

TRO has created an online, internal portal (UCL sign-in required) to showcase the breadth of biomedical expertise at UCL and our partner hospitals, aiming to facilitate multidisciplinary collaborations and capabilities mapping.Ìý

• Ìýto get your capabilities visibleÌýacross UCL experts and potentially external partners facilitated by TRO, leading to collaboration and funding opportunities.